Beneficial biological effects of Flavokawain A, a chalcone constituent from kava, on surgically induced endometriosis rat model
article
OA: closed
CC0
⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Flavokawain A, a compound from kava, demonstrated beneficial biological effects in a rat model of surgically induced endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (55)
- Ameliorative effects of luteolin against endometriosis progression in vitro and in vivo via openalex
- Apoptosis in human endometrium and endometriosis via openalex
- Curcumin attenuates proangiogenic and proinflammatory factors in human eutopic endometrial stromal cells through the NF‐κB signaling pathway via openalex
- Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis via openalex
- Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Epidemiologic and Genetic Associations of Endometriosis With Depression, Anxiety, and Eating Disorders via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Inflammasome as a Key Pathogenic Mechanism in Endometriosis via openalex
- Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9 via openalex
- Optimal Management of Endometriosis and Pain via openalex
- Pathogenesis of endometriosis via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies via openalex
- Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. via openalex
- The effects of isoliquiritigenin on endometriosis in vivo and in vitro study via openalex
- The Impact of Endometriosis on Quality of Life in Adolescents via openalex
- Viburnum opulus L.: A remedy for the treatment of endometriosis demonstrated by rat model of surgically-induced endometriosis via openalex
- W2161820045 via openalex
- W2150026213 via openalex
- W2136452337 via openalex
- W2272108953 via openalex
- W2415811595 via openalex
- W2418067973 via openalex
- W2126371827 via openalex
- W2109526314 via openalex
- W2547349119 via openalex
- W2620769476 via openalex
- W2744377419 via openalex
- W2798144402 via openalex
- W2804636211 via openalex
- W2808597917 via openalex
- W2103607628 via openalex
- W2095689910 via openalex
- W2079190330 via openalex
- W2072002828 via openalex
- W2996987372 via openalex
- W3009401109 via openalex
- W3027754211 via openalex
- W1996610518 via openalex
- W3034735374 via openalex
- W3089398080 via openalex
- W1996123579 via openalex
- W3118554437 via openalex
- W3134885188 via openalex
- W3195706465 via openalex
- W3207105154 via openalex
- W1967159292 via openalex
- W1965518808 via openalex
- W1803695511 via openalex
- W6777889331 via openalex
- W6800384597 via openalex
- W6846860059 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-28T00:33:38.251616+00:00
License: CC0
· commercial use OK